化疗端口相关并发症及其管理。
Chemoport-associated Complications and Its Management.
作者信息
Vinchurkar Kumar M, Maste Preeti, Togale Manoj D, Pattanshetti Vishwanath M
机构信息
Department of Surgical Oncology, JNMC KAHER, Belagavi, India.
KLES Dr Prabhakar Kore Hospital & MRC, Belagavi, India.
出版信息
Indian J Surg Oncol. 2020 Sep;11(3):394-397. doi: 10.1007/s13193-020-01067-w. Epub 2020 May 3.
Abstract
Chemoport is being routinely used to administer chemotherapy, blood, blood products, total parenteral nutrition, and also to draw blood for investigations. We started using chemoport in our institute. We use it exclusively to administer chemotherapy. We analyzed our results of chemoport usage and confirm that the rate of complications associated with chemoport usage is at par with the available literature. We also conclude that with regular use, the intra-op and post-op complications will reduce further.
摘要
化疗端口通常用于进行化疗、输注血液、血液制品、全胃肠外营养，也用于采集血样进行检查。我们所在机构开始使用化疗端口。我们仅将其用于化疗。我们分析了化疗端口的使用结果，并确认与化疗端口使用相关的并发症发生率与现有文献报道相当。我们还得出结论，随着常规使用，术中及术后并发症将进一步减少。
相似文献
1
Chemoport-associated Complications and Its Management.
Indian J Surg Oncol. 2020 Sep;11(3):394-397. doi: 10.1007/s13193-020-01067-w. Epub 2020 May 3.
2
A Spectrum of Chemoport-Associated Complications and Their Management in Cancer Patients.
Cureus. 2024 Apr 11;16(4):e58052. doi: 10.7759/cureus.58052. eCollection 2024 Apr.
3
Complications of chemoport in children with cancer: Experience of 54,100 catheter days from a tertiary cancer center of Southern India.
South Asian J Cancer. 2015 Jul-Sep;4(3):143-5. doi: 10.4103/2278-330X.173179.
4
Chemoport with a non-collapsible chamber as a replacement for an Ommaya reservoir in the treatment of leptomeningeal carcinomatosis.
Acta Neurochir (Wien). 2011 Oct;153(10):1971-8; discussion 1978. doi: 10.1007/s00701-011-1086-2. Epub 2011 Jul 28.
5
Modified Technique of Chemoport Placement in Severely Obese Patient for Administration of Chemotherapy.
Indian J Surg. 2023 Apr 3:1-3. doi: 10.1007/s12262-023-03749-5.
6
Bacteremia due to in a Patient with a Chemoport.
Infect Chemother. 2019 Jun;51(2):191-195. doi: 10.3947/ic.2019.51.2.191.
7
Catheter Fracture of Subclavian Venous Chemoport Device at Costoclavicular Junction: Pinch-off Syndrome.
Indian J Surg Oncol. 2018 Dec;9(4):595-597. doi: 10.1007/s13193-018-0802-2. Epub 2018 Jul 30.
8
"Difficult to flush chemoport: an important clinical sign".
Indian J Surg Oncol. 2014 Dec;5(4):307-9. doi: 10.1007/s13193-014-0354-z. Epub 2014 Sep 4.
9
Successful removal of embolized chemoport catheter within the heart and pericardium: 3 case reports.
J Thorac Dis. 2017 Aug;9(8):E718-E722. doi: 10.21037/jtd.2017.07.15.
10
Spontaneous chemoport fracture and cardiac migration.
Indian J Surg Oncol. 2014 Dec;5(4):325-6. doi: 10.1007/s13193-014-0353-0. Epub 2014 Sep 8.
引用本文的文献
1
A Comparative Study of Complications Related to Chemoport and Peripheral Line Among Cancer Patients Receiving Chemotherapy in Teaching Hospitals.
J Pharm Bioallied Sci. 2025 Jun;17(Suppl 2):S1197-S1199. doi: 10.4103/jpbs.jpbs_1588_24. Epub 2025 Jun 18.
2
Comparison of outcomes for chemo-port implantation performed in the operating room and interventional radiology suite: a retrospective observational study.
Ann Surg Treat Res. 2025 Jun;108(6):362-366. doi: 10.4174/astr.2025.108.6.362. Epub 2025 Jun 2.
3
The correlation between subcutaneous fat thickness and the incidence of chemoport-related infection.
Infect Prev Pract. 2024 Dec 5;7(1):100433. doi: 10.1016/j.infpip.2024.100433. eCollection 2025 Mar.
4
Clinical Safety and Efficiency of the H-Port for Treatment of Leptomeningeal Metastasis.
J Korean Neurosurg Soc. 2024 Jul;67(4):467-476. doi: 10.3340/jkns.2023.0178. Epub 2023 Dec 8.
5
Chemoport Fracture due to Catheter Pinch Off Syndrome: A Rare Complication of Subclavian Vein Approach Revisited.
Indian J Surg Oncol. 2022 Jun;13(2):343-347. doi: 10.1007/s13193-021-01459-6. Epub 2021 Oct 9.
本文引用的文献
1
Totally Implantable Venous Access Devices: A Review of Complications and Management Strategies.
Am J Clin Oncol. 2017 Feb;40(1):94-105. doi: 10.1097/COC.0000000000000361.
2
Central venous catheter-related thrombosis.
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):306-11. doi: 10.1182/asheducation-2014.1.306. Epub 2014 Nov 18.
3
4
Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution.
BMC Surg. 2014 May 8;14:27. doi: 10.1186/1471-2482-14-27.
5
Management of infections related to totally implantable venous-access ports: challenges and perspectives.
Lancet Infect Dis. 2014 Feb;14(2):146-59. doi: 10.1016/S1473-3099(13)70266-4. Epub 2013 Dec 5.
6
Totally implantable central venous catheters for chemotherapy: experience with 793 patients.
Rev Col Bras Cir. 2013 May-Jun;40(3):186-90. doi: 10.1590/s0100-69912013000300004.
7
Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients.
Ann Oncol. 2013 Feb;24(2):463-468. doi: 10.1093/annonc/mds468. Epub 2012 Oct 11.
8
Update on totally implantable venous access devices.
Surg Oncol. 2012 Sep;21(3):207-15. doi: 10.1016/j.suronc.2012.02.003. Epub 2012 Mar 17.
9
Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
Eur J Surg Oncol. 2011 Oct;37(10):913-8. doi: 10.1016/j.ejso.2011.06.016. Epub 2011 Aug 9.
10
Eliminating arterial injury during central venous catheterization using manometry.
Anesth Analg. 2009 Jul;109(1):130-4. doi: 10.1213/ane.0b013e31818f87e9. Epub 2009 Apr 17.
Zotero 插件